Ultrastructural aspects of cytomegalovirus-infected fibroblastic stromal cells of human bone marrow

被引:7
作者
Nassiri, MR
Gilloteaux, J
Taichman, RS
Drach, JC
机构
[1] Lake Erie Coll Osteopath Med, Dept Clin Pharmacol & Toxicol, Div Preclin Sci, Erie, PA 16509 USA
[2] Univ Michigan, Sch Dent, Dept Peridont & Geriatr, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA
关键词
human cytomegalovirus; bone marrow fibroblastic stromal cells; ultrastructure; nucleus; dense bodies;
D O I
10.1016/S0040-8166(98)80054-2
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Human cytomegalovirus (HCMV) and bone marrow interactions are important in the pathogenesis of HCMV infections. Human bone marrow fibroblastic stromal cells (HBFM-sc) were infected by Towne strain of cytomegalovirus (CMV) in cell culture. Several cytostructural features of control bone marrow stromal cells are described and compared with those of CMV-infected cells. Under these experimental conditions, HBFM-sc are cell types that can be successfully infected by CMV in vitro. The CMV-infected cells displayed typical features characteristic of DNA virus infections, such as cellular swelling, intranuclear inclusions, nucleolar condensation and disappearance (at the end stage), nuclear envelope proliferation as redundant folds, Other characteristics of CVM-infected cells include mitochondrial enlargement and vacuolization, cytoplasmic dense bodies associated or not with viral particles, accumulation and extrusion of viral particles and dense bodies. These preliminary observations shed some right on human bone-marrow stromal-cell morphology and function, one of the latter being that of a potentially harmful reservoir for CMV virus.
引用
收藏
页码:398 / 406
页数:9
相关论文
共 60 条
[1]  
ALBRECHT T, 1980, LAB INVEST, V42, P1
[2]  
[Anonymous], 1907, ZENTRALBL ALLG PATHO
[3]  
[Anonymous], 1904, ZENTRALBL ALLG PATHO
[4]  
[Anonymous], 1904, MUNCH WED WOCHENSCHR
[5]  
BESHORNER WE, 1980, AM J PATHOL, V99, P369
[6]   CYTOMEGALOVIRUS IMMUNE GLOBULIN AND SERONEGATIVE BLOOD PRODUCTS TO PREVENT PRIMARY CYTOMEGALOVIRUS-INFECTION AFTER MARROW TRANSPLANTATION [J].
BOWDEN, RA ;
SAYERS, M ;
FLOURNOY, N ;
NEWTON, B ;
BANAJI, M ;
THOMAS, ED ;
MEYERS, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (16) :1006-1010
[7]  
BRITT WJ, 1996, FIELDS VIROLOGY, P2493
[8]  
CATTORETTI G, 1993, BLOOD, V81, P1726
[9]   Biology of bone marrow stroma [J].
Clark, BR ;
Keating, A .
BONE MARROW TRANSPLANTATION: FOUNDATIONS FOR THE 21ST CENTURY, 1995, 770 :70-78
[10]  
EGGERS M, 1992, J GEN VIROL, V279, P753